Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Tract Infections 1 Urinary Bladder Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Infections 1 Advanced Gastric Carcinoma 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 9 Ciprofloxacin 7 Voriconazole 5 Caspofungin 4 Amoxicillin-Potassium Clavulanate Combination 4 gamma-Globulins 3 Vancomycin 3 Fluconazole 3 Filgrastim 3 Daptomycin 3 Antibiotic Prophylaxis 3 plerixafor 2 liposomal amphotericin B 2 Trimethoprim 2 Therapeutics 2 Sulfamethoxazole 2 Saline Solution 2 Ribavirin 2 Polymerase Chain Reaction 2 Peripheral Blood Stem Cell Transplantation 2 Pentetic Acid 2 Moxifloxacin 2 Melphalan 2 Levofloxacin 2 Itraconazole 2 Immunoglobulins, Intravenous 2 Granulocyte Colony-Stimulating Factor 2 Ethanol 2 Cyclophosphamide 2 Cefazolin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Infections × Fosfomycin × Clear all

NCT03228108 2022-05-10

pro-SWAP

Radboud University Medical Center

Phase 4 Completed

Infections, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡